share_log

绿叶制药(02186.HK)获瑞银增持356.95万股普通股股份,价值约1,049.04万港元

Luye Pharmaceuticals (02186.HK) received an increase of its common shares by 3,569,500 shares from UBS, worth approximately HK$10.494 million

Futu News ·  May 8 17:04

On May 8, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 8, UBS Group AG (UBS Group AG) increased its holdings at an average price of HK$2.9389 per share on May 2$LUYE PHARMA (02186.HK)$3,569,500 common shares worth approximately HK$10.494 million. After the increase in holdings, UBS's latest shareholding was 453 million shares, and the good position ratio increased from 11.94% to 12.04%.

Additional information: 218,500,000 of the long-term long and short positions refer to the securities lending agreement proposed in consideration with the convertible bond proposed as on June 28 2023.

HKEXAutoNews_CS20240507E00295.png

What is disclosure of interests?

As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.

Why is disclosure of interests important?

Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling the stock interests of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment